Pipex Pharma(PP)-- Top Pick 2007 Pipex Pharma (New on Amex: PP) Marketcap: 126 mio$ Cash: 12mio$ Price: 7,45$ Shares Out: 17 mio Coprexa (Wilson Disease) submit NDA in October 2007 Coprexa (Pulmonary Fibrosis) start Phase II/III in 2H 2007 Trimesta Oral (Multiple Sclerosis) Phase II/III ongoing Pipeline: <A HREF="http://www.pipexpharma.com/pipeline.html" target="_blank">http://www.pipexpharma.com/pipeline.html</A> Over the last few weeks Pipex Pharma CEO Steve Kanzer has bought over 350,000 shares worth close to $2,3M. <A HREF="http://finance.yahoo.com/q/it?s=PP" target="_blank">http://finance.yahoo.com/q/it?s=PP</A> INSIDE WALL STREET: A Promising Pipeline At Pipex <A HREF="http://www.businessweek.com/magazine/content/07_31/b4044083.htm?campaign_id=yhoo" target="_blank">http://www.businessweek.com/magazine/content/07_31/b4044083.htm?campaign_id=yhoo</A> Promising prescription: $5.5B market waiting as Pipex tests 2 drugs By Andrew Dietderich June 25, 2007 <A HREF="http://crainsdetroit.com/apps/pbcs.dll/article?AID=/20070625/SUB/70623005/-1/toc" target="_blank">http://crainsdetroit.com/apps/pbcs.dll/article?AID=/20070625/SUB/70623005/-1/toc</A>